Daniel GoldmanSell
CDNA · Transaction Mar 6, 2023 · Filed Apr 17, 2023 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · CDNA
0.00% · $0.0000 · Vol Not reported
Market closed · last close shown
CareDx Inc
Biotechnology
$53.83
Follow $CDNA
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $CDNA by emailVeridion Score
BETAMEDIUM CONF · 6 of 6 factors measuredFri Sep 18 · last completed session · Pre-market · regular session opens 9:30 ET · CDNA
MethodologyCDNA
CareDx Inc
Fri Sep 18 · last completed session · Pre-market · regular session opens 9:30 ET
Upper range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
80/ 100
Veridion Score
Upper range · MEDIUM confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 6 of 6 factors measured · Fri Sep 18 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is CDNA moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About CareDx Inc
SERVICES-MEDICAL LABORATORIESListed since
2014
Employees
765
Country
US
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$53.83
Last session
Day high
$53.83
Last session
Day low
$53.83
Last session
Previous close
$53.83
52W high
$54.28
-0.83% from high
52W low
$14.28
99% of range
Market cap
$2.8B
P/E
27.05×
EPS
$1.99
Beta
1.06
Shares out
51.7M
Avg volume
1.1M
VWAP
$53.83
Last session
Price history computed in-house
1W
+2.79%
1M
+10.74%
3M
+114.29%
1Y
+268.95%
YTD
+185.72%
SMA 50 $44.88 · above
SMA 200 $26.63 · above
52W position 99%
CDNA overview
Related filings and maps
Public disclosures
Congress activity in CDNA
Official filing ↗
CareDx, Inc. · Transaction Mar 6, 2023 · Filed Apr 17, 2023 · $1,001 to $15,000
CareDx, Inc. · Transaction Mar 2, 2021 · Filed Apr 10, 2021 · $15,001 to $50,000
CDNA · Transaction Mar 2, 2021 · Filed Apr 10, 2021 · $15,001 to $50,000
Tom MalinowskiSell
CDNA · Transaction Jan 11, 2021 · Filed Aug 26, 2021 · $1,001 to $15,000
Federal contracts
CDNA contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CDNA in this window.
Lobbying spend
CDNA lobbying filings, year to date.
Registered lobbying filings matched to CareDx Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CDNA in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for CDNA.
Options
Sovereign unlock shows live options positioning for CDNA.